Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Food or edible as carrier for pharmaceutical
Reexamination Certificate
2011-08-09
2011-08-09
Desai, Anand (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Food or edible as carrier for pharmaceutical
Reexamination Certificate
active
07993668
ABSTRACT:
As a nutritional composition and a composition for the prophylaxis or improvement of lower gastrointestinal function, which improve lower gastrointestinal function and are effective for the prophylaxis or improvement of diarrhea, gastroesophageal reflux or misswallowing caused by administration of a liquid nutritional supplement, the present invention provides a nutritional composition and a composition for the prophylaxis or improvement of lower gastrointestinal function, which comprise at least one kind selected from glutamic acid, 5′-nucleotide and a salt thereof, wherein, when glutamic acid alone is contained, the content thereof on administration is 0.0013-1.3 w/v % as free glutamic acid.
REFERENCES:
patent: 3156569 (1964-11-01), Griffin et al.
patent: 3821471 (1974-06-01), Bauer
patent: 3832471 (1974-08-01), Siregar
patent: 4176201 (1979-11-01), Cook
patent: 06303918 (1994-11-01), None
patent: 7-330583 (1995-12-01), None
patent: 2003-524636 (2003-08-01), None
patent: 2003-530411 (2003-10-01), None
patent: 2004313178 (2004-11-01), None
patent: 98/32429 (1998-07-01), None
patent: 01/45691 (2001-06-01), None
patent: 01/78532 (2001-10-01), None
patent: 02/062324 (2002-08-01), None
Glutamic Acid. WWW.nutros.com
sr-0200d.html.
WebMD article, Causes of Diarrhea, accessed May 31, 2010.
L. S. Vasilevskaia, et al. “Effect of glutamate and combined with inosine monophosphate on gastric secretion” Database Medline, US National Library of Medicine, May 1993, XP-002445428, p. 1-1.
Jean-Pierre Kessler, et al. “Evidence that activation of N-methyl-D-aspartate (NMDA) and non-NMDA receptors within the nucleus tractus solitarii triggers swallowing” European Journal of Pharmacology, vol. 201, 1991, XP-002447629, pp. 59-67.
Pamela J Hornby, “Receptors and Transmission in the Brain-Gut Axis II. Excitatory amino acid receptors in the brain-gut axis” American Journal of Physiology: Gastrointestinal and Liver Physiology, American Physiological Society, US, vol. 280, No. 6, 2001, XP-002999857, pp. G1055-G1060.
R. Norton et al, “Use of nucleotides in weanling rats with diarrhea induced by a lactose overload: effect on the evolution of diarrhea and weight and on the histopathology of intestine, liver and spleen”,Brazilian Journal of Medical and Biological Research, 2001, vol. 34, No. 2, pp. 195-202.
M. Ando, “Amino acid metabolism and water transport across the seawater eel intestine”,Journal of Experimental Biology, 1988, vol. 138, pp. 93-106.
M. Ando, “Regulation by intracellular alanine of water transport across the seawater eel intestine”,Zoological Science, 1987, vol. 4, No. 1, pp. 37-44.
U.S. Appl. No. 11/687,805, filed Mar. 19, 2007, Uneyama, et al.
S. Iijima et al.,The Journal of Nutrition, 126: pp. 589-595 (1996).
Arnaud et al., Journal of Pediatric Gastroenterology and Nutrition, vol. 37 No. 2 (2003) pp. 124-131.
European Search Report issued Feb. 2, 2011 in Application EP 10011493.3.
Miwa Kiyoshi
Tanaka Tatsuro
Torii Kunio
Uneyama Hisayuki
Ajinomoto Co. Inc.
Desai Anand
Mercier Melissa S
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
LandOfFree
Nutrient composition and composition for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nutrient composition and composition for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nutrient composition and composition for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2712788